Indications |
Oral Mild to moderate pain Adult: 500 mg to 1 g every 4-8 hr. Max: 4 g/day. Child: 12-15 yr: 500 mg once or bid. Max: 1 g daily. >15 yr: 500 mg to 1 g every 4-8 hr. Max: 4 g/day. Oral Acute migraine attacks Adult: 1 g every 4-8 hr. Max: 4 g/day. Child: >15 yr: 1 g every 4-8 hr. Max: 4 g/day. Otic/Aural Otic inflammation Adult: 4-6 drops (0.5% solution) 3-4 times daily depending on the severity of inflammation. Otic/Aural Removal of earwax Adult: 4-6 drops (0.5% solution) 3-4 times daily depending on the severity of inflammation. |
Contraindications |
Allergy to pyrazolones or other NSAIDs. G6PD deficiency, porphyria. Otic/Aural: Perforated eardrums. |
Warnings / Precautions |
Pregnancy. History of blood disorders. |
Adverse Reactions |
Hypersensitivity reactions, nephrotoxicity. Nausea, drowsiness, convulsive crisis, agranulocytosis, leucopenia. Potentially Fatal: Coma (large oral doses), severe skin eruptions. |
Drug Interactions |
May affect metabolism of drugs metabolised by liver enzymes. Metabolism may be affected by liver enzyme inhibitors or inducers. See Below for More phenazone Drug Interactions |
Mechanism of Actions |
Phenazone is an NSAID. Absorption: Absorbed from the GI tract. Peak plasma concentrations within 1-2 hr. Distribution: Throughout the body fluids; concentrations in the saliva and breast milk reaching about the same levels as those in plasma. Protein-binding: <10%. Metabolism: Hepatic; metabolised to 3 major metabolites. Excretion: Mainly via urine; via bile (small amount). Elimination half-life: About 12 hr. |
Storage Conditions |
Otic/Aural: Store below 25°C. |
ATC Classification |
N02BB01 - phenazone ; Belongs to the class of pyrazolone preparations. Used to relieve pain and fever. |
Storage |
Otic/Aural: Store below 25°C. |
Available As |
|
Phenazone
Post Review about Phenazone Click here to cancel reply.
Phenazone Containing Brands
Phenazone is used in following diseases
Drug - Drug Interactions of Phenazone
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.